The Tissue-Reconstructing Ability of Colon CSCs Is Enhanced by FK506 and Suppressed by GSK3 Inhibition

This study identifies signaling pathways that contribute to the tissue-reconstructing capacity of colon CSCs and suggests that clinically used drugs could be repurposed to improve unresectable colon cancers. Mol Cancer Res; 15(10); 1455–66. ©2017 AACR.

Source: Molecular Cancer Research - October 1, 2017 Category: Cancer & Oncology Authors: Ishida, R., Koyanagi-Aoi, M., Oshima, N., Kakeji, Y., Aoi, T. Tags: Signal Transduction Source Type: research